nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—TNNC1—MFAP5-mediated ovarian cancer cell motility and invasiveness—PTK2—malignant glioma	0.148	0.148	CbGpPWpGaD
Levosimendan—TNNC1—Muscle contraction—MYLK—malignant glioma	0.114	0.114	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—NF1—malignant glioma	0.043	0.043	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—RUNX3—malignant glioma	0.0344	0.0344	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—TFRC—malignant glioma	0.0326	0.0326	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—MYB—malignant glioma	0.0318	0.0318	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—SOX2—malignant glioma	0.0307	0.0307	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—YWHAE—malignant glioma	0.0238	0.0238	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—NTRK2—malignant glioma	0.0238	0.0238	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—GJA1—malignant glioma	0.0196	0.0196	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—DOCK6—malignant glioma	0.0173	0.0173	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—F2—malignant glioma	0.0172	0.0172	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—HES1—malignant glioma	0.0171	0.0171	CbGpPWpGaD
Levosimendan—KCNJ11—Type II diabetes mellitus—TNF—malignant glioma	0.0147	0.0147	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—BCHE—malignant glioma	0.0146	0.0146	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—HIF1A—malignant glioma	0.0143	0.0143	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—SLC6A3—malignant glioma	0.0137	0.0137	CbGpPWpGaD
Levosimendan—PDE3A—Platelet homeostasis—PTPN11—malignant glioma	0.0115	0.0115	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ATP1B2—malignant glioma	0.0105	0.0105	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CXCL8—malignant glioma	0.00929	0.00929	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—IL1B—malignant glioma	0.00891	0.00891	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—CASP3—malignant glioma	0.00889	0.00889	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—RTEL1—malignant glioma	0.00819	0.00819	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ANGPT2—malignant glioma	0.00771	0.00771	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—VEGFA—malignant glioma	0.00755	0.00755	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—BRAF—malignant glioma	0.00745	0.00745	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—BCHE—malignant glioma	0.00691	0.00691	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—HIST1H3B—malignant glioma	0.00667	0.00667	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MYB—malignant glioma	0.00661	0.00661	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LATS2—malignant glioma	0.00656	0.00656	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—SLC6A3—malignant glioma	0.0065	0.0065	CbGpPWpGaD
Levosimendan—KCNJ8—SIDS Susceptibility Pathways—TNF—malignant glioma	0.00647	0.00647	CbGpPWpGaD
Levosimendan—KCNJ11—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.00628	0.00628	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—MDM2—malignant glioma	0.00624	0.00624	CbGpPWpGaD
Levosimendan—KCNJ8—Neuronal System—RAF1—malignant glioma	0.00622	0.00622	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—H3F3A—malignant glioma	0.00516	0.00516	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LATS1—malignant glioma	0.00498	0.00498	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—COX8A—malignant glioma	0.0047	0.0047	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CCR4—malignant glioma	0.00434	0.00434	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—KNG1—malignant glioma	0.00425	0.00425	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IFNA2—malignant glioma	0.00416	0.00416	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ASMT—malignant glioma	0.004	0.004	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SOD1—malignant glioma	0.00395	0.00395	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCR4—malignant glioma	0.00394	0.00394	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—BCAN—malignant glioma	0.00376	0.00376	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PTK2—malignant glioma	0.00362	0.00362	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—BRAF—malignant glioma	0.00353	0.00353	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MDK—malignant glioma	0.00336	0.00336	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCR3—malignant glioma	0.00323	0.00323	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—DTX1—malignant glioma	0.00321	0.00321	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PDGFB—malignant glioma	0.00304	0.00304	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—IDH2—malignant glioma	0.00303	0.00303	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—MDM2—malignant glioma	0.00296	0.00296	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—BDKRB2—malignant glioma	0.00295	0.00295	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—RAF1—malignant glioma	0.00295	0.00295	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCR3—malignant glioma	0.00293	0.00293	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—CAV1—malignant glioma	0.00289	0.00289	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP2B6—malignant glioma	0.00285	0.00285	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—F2—malignant glioma	0.00275	0.00275	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—FN1—malignant glioma	0.00275	0.00275	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—KNG1—malignant glioma	0.00269	0.00269	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—BDKRB2—malignant glioma	0.00268	0.00268	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CG—malignant glioma	0.00263	0.00263	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—IDH1—malignant glioma	0.00261	0.00261	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—EGF—malignant glioma	0.0026	0.0026	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PTPN11—malignant glioma	0.00258	0.00258	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SUFU—malignant glioma	0.00255	0.00255	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SPHK1—malignant glioma	0.00252	0.00252	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HEY2—malignant glioma	0.00252	0.00252	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP2C18—malignant glioma	0.00247	0.00247	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GFAP—malignant glioma	0.00246	0.00246	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—KNG1—malignant glioma	0.00244	0.00244	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—AKT2—malignant glioma	0.0024	0.0024	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SPHK1—malignant glioma	0.00238	0.00238	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCR4—malignant glioma	0.00233	0.00233	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HEY1—malignant glioma	0.00233	0.00233	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CD—malignant glioma	0.00231	0.00231	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HIST1H3B—malignant glioma	0.00226	0.00226	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MMP3—malignant glioma	0.00216	0.00216	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JAG2—malignant glioma	0.00207	0.00207	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—RAF1—malignant glioma	0.00206	0.00206	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CB—malignant glioma	0.00201	0.00201	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTT1—malignant glioma	0.002	0.002	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTGS1—malignant glioma	0.00187	0.00187	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IL2—malignant glioma	0.00185	0.00185	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—H3F3A—malignant glioma	0.00175	0.00175	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—BCHE—malignant glioma	0.00174	0.00174	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—F2—malignant glioma	0.00174	0.00174	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCR3—malignant glioma	0.00173	0.00173	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC5A5—malignant glioma	0.00172	0.00172	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—YWHAE—malignant glioma	0.00168	0.00168	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NTRK2—malignant glioma	0.00168	0.00168	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FLT1—malignant glioma	0.00168	0.00168	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—DUSP6—malignant glioma	0.00167	0.00167	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CG—malignant glioma	0.00166	0.00166	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JAG1—malignant glioma	0.00165	0.00165	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH3—malignant glioma	0.00164	0.00164	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FBXW7—malignant glioma	0.00161	0.00161	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—BDKRB2—malignant glioma	0.00158	0.00158	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—F2—malignant glioma	0.00158	0.00158	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VEGFA—malignant glioma	0.00157	0.00157	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AKT2—malignant glioma	0.00152	0.00152	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CG—malignant glioma	0.00151	0.00151	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PTPN11—malignant glioma	0.00148	0.00148	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH2—malignant glioma	0.00147	0.00147	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CD—malignant glioma	0.00146	0.00146	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KNG1—malignant glioma	0.00144	0.00144	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTP1—malignant glioma	0.00139	0.00139	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AKT2—malignant glioma	0.00138	0.00138	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NTRK1—malignant glioma	0.00137	0.00137	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CAT—malignant glioma	0.00135	0.00135	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—KRAS—malignant glioma	0.00134	0.00134	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CD—malignant glioma	0.00133	0.00133	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MMP3—malignant glioma	0.00128	0.00128	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NCOR1—malignant glioma	0.00127	0.00127	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CB—malignant glioma	0.00127	0.00127	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CDKN2B—malignant glioma	0.00127	0.00127	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTK2—malignant glioma	0.00123	0.00123	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CA—malignant glioma	0.00123	0.00123	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCL8—malignant glioma	0.00122	0.00122	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HES1—malignant glioma	0.00121	0.00121	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NCOR1—malignant glioma	0.0012	0.0012	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TP53—malignant glioma	0.00119	0.00119	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—RAF1—malignant glioma	0.00118	0.00118	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—IL2—malignant glioma	0.00117	0.00117	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CB—malignant glioma	0.00116	0.00116	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDGFRA—malignant glioma	0.00115	0.00115	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SPP1—malignant glioma	0.00112	0.00112	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCL8—malignant glioma	0.00111	0.00111	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL2—malignant glioma	0.00106	0.00106	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TERT—malignant glioma	0.00106	0.00106	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CAV1—malignant glioma	0.00104	0.00104	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDGFB—malignant glioma	0.00103	0.00103	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGFR1—malignant glioma	0.00103	0.00103	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HIF1A—malignant glioma	0.00101	0.00101	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—AKT1—malignant glioma	0.001	0.001	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CAV1—malignant glioma	0.000978	0.000978	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KDR—malignant glioma	0.000967	0.000967	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CG—malignant glioma	0.000945	0.000945	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FN1—malignant glioma	0.000931	0.000931	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—F2—malignant glioma	0.000931	0.000931	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—BAD—malignant glioma	0.00092	0.00092	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPARG—malignant glioma	0.000912	0.000912	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOTCH1—malignant glioma	0.000911	0.000911	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CD80—malignant glioma	0.000893	0.000893	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CG—malignant glioma	0.000891	0.000891	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APC—malignant glioma	0.000891	0.000891	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGF—malignant glioma	0.000881	0.000881	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTPN11—malignant glioma	0.000875	0.000875	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—BRAF—malignant glioma	0.000838	0.000838	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CD—malignant glioma	0.000831	0.000831	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKT2—malignant glioma	0.000815	0.000815	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EGFR—malignant glioma	0.000812	0.000812	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CD—malignant glioma	0.000783	0.000783	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CA—malignant glioma	0.000776	0.000776	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—KRAS—malignant glioma	0.000767	0.000767	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF2—malignant glioma	0.00075	0.00075	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CB—malignant glioma	0.000724	0.000724	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTGS2—malignant glioma	0.000718	0.000718	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CA—malignant glioma	0.000705	0.000705	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MDM2—malignant glioma	0.000702	0.000702	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RAF1—malignant glioma	0.000699	0.000699	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ERBB2—malignant glioma	0.000692	0.000692	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CB—malignant glioma	0.000683	0.000683	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL8—malignant glioma	0.000656	0.000656	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AKT1—malignant glioma	0.000634	0.000634	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CASP3—malignant glioma	0.000628	0.000628	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL2—malignant glioma	0.000627	0.000627	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTEN—malignant glioma	0.000626	0.000626	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MMP9—malignant glioma	0.000593	0.000593	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PTEN—malignant glioma	0.00059	0.00059	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AKT1—malignant glioma	0.000576	0.000576	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VEGFA—malignant glioma	0.000533	0.000533	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STAT3—malignant glioma	0.000528	0.000528	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MYC—malignant glioma	0.00049	0.00049	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EGFR—malignant glioma	0.00048	0.00048	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KRAS—malignant glioma	0.000453	0.000453	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CA—malignant glioma	0.000441	0.000441	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CA—malignant glioma	0.000416	0.000416	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TP53—malignant glioma	0.000403	0.000403	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AKT1—malignant glioma	0.000361	0.000361	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKT1—malignant glioma	0.00034	0.00034	CbGpPWpGaD
